IIT Kharagpur’s COVIRAP test could change the COVID-19 testing in India: All you need to know

By: |
October 22, 2020 11:57 AM

India currently has two testing methods - the RT-PCR and the rapid antigen tests.

IIT-KGP has said that the efficacy of the test’s method has been validated by the ICMR. (Image: IIT KGP Twitter)

Coronavirus testing: Indian Institute of Technology, Kharagpur’s COVID-19 diagnostic test could be a game changer! IIT-Kharagpur has developed a new diagnostic test called COVIRAP for coronavirus, and it can help bring high-end molecular diagnostics technology out of the labs and into the fields, according to a report by IE. The institute has said that the efficacy of the test’s method has been validated by the Indian Council of Medical Research (ICMR), the report added.

How does COVIRAP work?

The test contains an automated pre-programmable unit to control temperature, a genomic analysis special detection unit, and a smartphone app customised for the results.

The report cited IIT-Kharagpur’s Dean of Sponsored Research and Industrial Consultancy Prof Suman Chakraborty as saying that there are three master mixes which work as markers of different genes in order to confirm whether SARS-CoV-2, the coronavirus causing COVID-19, is present.

Assistant Professor at IIT-Kharagpur School of Bioscience Dr Arindam Mondal was cited as saying that the technology has undergone rigorous testing protocols as directed by the ICMR guidelines.

COVID-19 testing: Significance of IIT-Kharagpur’s test

India currently has two testing methods – the RT-PCR and the rapid antigen tests. While the RT-PCR tests are accurate, they require lab infrastructure which is advanced. On the other hand, rapid antigen can produce results quickly, but the accuracy levels are low.

The report cited IIT-Kharagpur Director Prof V K Tiwari as saying that the process of testing with COVIRAP can be completed within an hour. Moreover, the test’s unit is ultra-low-cost and portable, and it can be operated outside the laboratory by unskilled operators as well. Prof Tiwari said that the test unit is an alternative to the high-end machines used for RT-PCR. Samples in open fields can also be tested using COVIRAP, and a single unit can help in testing a large number of samples after simply replacing the paper cartridge after every test.

The machine, which has been patented by the institute, has been made very generic, and it can be used to test other infections as well, including dengue, influenza, TB, Japanese encephalitis and malaria.


The FELUDA test, developed by the Institute of Genomics and Integrative Biology, is also meant to detect genes specific to the novel coronavirus with minimal technical expertise. The FELUDA test uses the CRISPR-CAS technology, and its current prototype needs to be processed using a PCR machine. However, COVIRAP uses a separate detection technology, which has been developed and patented by IIT-Kharagpur, the report said.

Prof Chakraborty said that the method used by their test contains certain components that are exclusive to it and are different from the CRISPR-CAS technology.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Lockdown should be last resort: PM Modi
2Govt aid will help vaccine production, says Poonawalla
3Vaccine ramp-up: Advance of Rs 4,500 crore to be paid to SII, Bharat Biotech